mTOR: Maybe MRK can finally find an indication for ridaforolimus
:)
Seriously speaking, none of the oncology mTOR inhibitors have anywhere near good enough tolerability for this sort of application. Metformin is cheap and has a pretty benign side-effect profile.
Market Data 
Markets 
AI
